Modular droplet injector for sample conservation providing new structural insight for the conformational heterogeneity in the disease-associated NQO1 enzyme
Metadata
Show full item recordAuthor
Doppler, Diandra; Pey Rodríguez, Ángel Luis; Ruiz Fresneda, Miguel Ángel; Pacheco García, Juan LuisEditorial
Royal Society of Chemistry
Date
2023Referencia bibliográfica
Lab Chip, 2023, 23, 3016–3033 [10.1039/d3lc00176h]
Sponsorship
STC Program of the National Science Foundation through BioXFEL (under agreement # 1231306); ABI Innovations award (NSF # 1565180), IIBR award (# 1943448); MCB award (1817862); National Institutes of Health award # R01GM095583; US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract # DE-AC02- 76SF00515; Center for Structural Dynamics in Biology, NIH grant P41GM13968; “Ayuda de Atracción y Retención de Talento Investigador” from the Community of Madrid, Spain (REF: 2019-T1/BMD-15552); ERDF/Spanish Ministry of Science, Innovation, and Universities—State Research Agency (grant RTI2018-096246-B- I00), Consejería de Economía, Conocimiento, Empresas, y Universidad, Junta de Andalucía (grant P18-RT-2413),; ERDF/Counseling of Economic transformation, Industry, Knowledge, and Universities (grant B-BIO-84-UGR20)Abstract
Droplet injection strategies are a promising tool to reduce the large amount of sample consumed in serial
femtosecond crystallography (SFX) measurements at X-ray free electron lasers (XFELs) with continuous
injection approaches. Here, we demonstrate a new modular microfluidic droplet injector (MDI) design that
was successfully applied to deliver microcrystals of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)
and phycocyanin. We investigated droplet generation conditions through electrical stimulation for both
protein samples and implemented hardware and software components for optimized crystal injection at
the Macromolecular Femtosecond Crystallography (MFX) instrument at the Stanford Linac Coherent Light
Source (LCLS). Under optimized droplet injection conditions, we demonstrate that up to 4-fold sample
consumption savings can be achieved with the droplet injector. In addition, we collected a full data set with
droplet injection for NQO1 protein crystals with a resolution up to 2.7 Å, leading to the first room-
temperature structure of NQO1 at an XFEL. NQO1 is a flavoenzyme associated with cancer, Alzheimer's
and Parkinson's disease, making it an attractive target for drug discovery. Our results reveal for the first time
that residues Tyr128 and Phe232, which play key roles in the function of the protein, show an unexpected
conformational heterogeneity at room temperature within the crystals. These results suggest that different
substates exist in the conformational ensemble of NQO1 with functional and mechanistic implications for
the enzyme's negative cooperativity through a conformational selection mechanism. Our study thus
demonstrates that microfluidic droplet injection constitutes a robust sample-conserving injection method
for SFX studies on protein crystals that are difficult to obtain in amounts necessary for continuous injection,
including the large sample quantities required for time-resolved mix-and-inject studies.